Targeted Recombinant Viral Vectors
Patent Cooperation Treaty
PCT/US1998/021364
Filed on 1998-10-09
PCT/US1998/021364
Filed on 1998-10-09
Method And Composition for Inhibition of Tumor Growth and Enhancing an Immune Response
European Patent
01989341.1
Filed on 2001-10-22
01989341.1
Filed on 2001-10-22
METHODS FOR USE OF INTERLEUKIN 4 (IL-4) AND TUMOR NECROSIS FACTOR ALPHA (TNF-A) TO TREAT HUMAN IMMUNODEFICIENCY VIRUS INFECTION
Patent Cooperation Treaty
PCT/US1998/019616
Filed on 1998-09-18
PCT/US1998/019616
Filed on 1998-09-18
EXTENSION OF A PROTEIN-PROTEIN INTERACTION SURFACE TO INACTIVATE THE FUNCTION OF A CELLULAR PROTEIN
Patent Cooperation Treaty
PCT/US1996/012590
Filed on 1996-07-31
PCT/US1996/012590
Filed on 1996-07-31
NOVEL HUMAN CANCER ANTIGEN NY ESO-1/CAG-3 AND GENE ENCODING SAME
Patent Cooperation Treaty
PCT/US1998/019609
Filed on 1998-09-21
PCT/US1998/019609
Filed on 1998-09-21
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
Patent Cooperation Treaty
PCT/US1998/019794
Filed on 1998-09-22
PCT/US1998/019794
Filed on 1998-09-22
Induction of an Activated Myeloid Dendritic Cell Phenotype
Patent Cooperation Treaty
PCT/US1996/001090
Filed on 1996-01-26
PCT/US1996/001090
Filed on 1996-01-26
Restriction Display (rd-PCR) of Differentially Expressed mRNAs
US Patent 6,270,966
Filed on 1998-08-07
Filed on 1998-08-07
ACRIDONE-DERIVED COMPOUNDS USEFUL AS ANTINEOPLASTIC AND ANTIRETROVIRAL AGENTS
Patent Cooperation Treaty
PCT/US1997/007070
Filed on 1997-04-09
PCT/US1997/007070
Filed on 1997-04-09
ATTENUATED AND DOMINANT NEGATIVE VARIANT cDNAS OF STAT6: STAT6b and STAT6c (as filed)
Patent Cooperation Treaty
PCT/US1998/017821
Filed on 1998-08-27
PCT/US1998/017821
Filed on 1998-08-27